Synageva BioPharma Corp (NASDAQ:GEVA)

216.65
Delayed Data
As of 11:11am ET
 +0.86 / +0.40%
Today’s Change
60.19
Today|||52-Week Range
217.23
+133.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues2.3M1.3M1.2M927.0K
 
 
 
 
 
Depreciation And Amortization1.7M1.3M1.6M--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses50.9M48.1M56.9M59.9M
 
 
 
 
 
Other Operating Expenses0.000.000.00222.0K
 
 
Research And Development38.3M33.6M36.5M38.2M
 
 
 
 
 
Total Operating Expenses52.7M49.4M58.5M60.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-50.3M-48.0M-57.3M-59.2M
 
 
 
 
 
Pre-Tax Equity Earnings---400.0K-200.0K--
 
 
 
Other Expenses-9.0K88.0K288.0K-252.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-50.2M-48.3M-57.2M-59.3M
 
 
 
 
 
Income Taxes-16.0K-16.0K-490.0K-259.0K
 
 
 
 
 
Net Income-50.2M-48.3M-57.7M-59.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.1M33.2M33.3M36.5M
 
 
 
 
 
Shares To Calculate EPS Diluted33.1M33.2M33.3M36.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.52-$1.46-$1.73-$1.63
 
 
 
 
 
EPS Diluted-$1.52-$1.46-$1.73-$1.63
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account